Ziyong Hao
Overview
Explore the profile of Ziyong Hao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang W, Xu K, Fu X, Zhang W, Hao Z, Sang Z, et al.
Front Cardiovasc Med
. 2025 Feb;
12:1524390.
PMID: 39968339
Background: Previous intracoronary imaging studies have shown that coronary artery calcium (CAC) is an independent risk factor of stent underexpansion; however, limited preintervention assessments of CAC have been performed using...
2.
Hao Z, Liu B, Xie X, Fan Y, Wang J, Shao Q, et al.
Hellenic J Cardiol
. 2024 Mar;
PMID: 38460616
Background: The safety and efficacy of a combined approach of catheter ablation (CA) and left atrial appendage occlusion (LAAO) compared to LAAO alone remain unknown. Methods: Patients with atrial fibrillation...
3.
Xu K, Jiang Y, Yang W, Zhang W, Wang D, Zhao Y, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1217069.
PMID: 37600052
Introduction: In coronary bifurcation lesions treated with percutaneous coronary intervention (PCI) using a 1-stent strategy, the occurrence of side branch (SB) compromise may lead to long-term myocardial ischemia in the...
4.
Jiang L, Hao Z, Xie X, Xu K, Shen L, Pan X, et al.
EuroIntervention
. 2023 Aug;
19(8):695-702.
PMID: 37594402
Background: The current risk stratification schemes for stroke in patients with atrial fibrillation (AF) are insufficient for an accurate assessment of stroke risk. Aims: This study evaluates the association between...
5.
Zhang W, Dai J, Shen L, Jiang Y, Zheng X, Xu K, et al.
Front Cardiovasc Med
. 2022 Sep;
9:965364.
PMID: 36158840
Background: The optimum therapy for coronary slow flow phenomenon (CSFP) stays debatable. This study compared the effectiveness of alprostadil with isosorbide dinitrate in alleviating angina episodes in CSFP patients. Methods:...
6.
Zhang W, Dai J, Zheng X, Xu K, Yang X, Shen L, et al.
Medicine (Baltimore)
. 2021 Apr;
100(15):e25551.
PMID: 33847683
Background: The aim of the study was to evaluate the efficacy of nicorandil and alprostadil on myocardial protection in patients undergoing elective percutaneous coronary intervention (PCI). Methods: In this prospective,...
7.
Hao Z, Ma J, Dai J, Shao Q, Shen L, He B, et al.
Coron Artery Dis
. 2020 Mar;
31(5):424-429.
PMID: 32168044
Background: Cardiac rupture is a disastrous but uncommon complication of acute ST-elevation myocardial infarction (STEMI). The incidence, risk factors and in-hospital outcomes related to cardiac rupture in the current era...